|
|
|
Insider
Information: |
Harford Simon N.r. |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
164,365 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,743,913 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
164,365 |
|
|
Total
Value |
$1,743,913 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PAREXEL International |
PRXL |
See Remarks |
2017-09-29 |
0 |
2017-05-09 |
0 |
Premium* |
|
Albireo Pharma Inc |
ALBO |
CFO and Treasurer |
2023-03-02 |
0 |
2018-10-10 |
0 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
|
2024-01-02 |
164,365 |
2023-08-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRXL |
PAREXEL International |
SVP & Chief Financial Officer |
|
2017-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,736 |
10,736 |
0 |
- |
|
PRXL |
PAREXEL International |
See Remarks |
|
2017-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,736) |
0 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2023-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
106,973 |
106,973 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
57,392 |
164,365 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2018-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2020-01-10 |
4 |
AS |
$27.20 |
$2,856 |
D/D |
(105) |
4,895 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2020-04-13 |
4 |
AS |
$16.52 |
$1,602 |
D/D |
(97) |
4,798 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2020-07-10 |
4 |
AS |
$25.56 |
$2,352 |
D/D |
(92) |
4,706 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2020-10-12 |
4 |
AS |
$37.30 |
$3,357 |
D/D |
(90) |
4,616 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2021-01-11 |
4 |
AS |
$37.33 |
$4,107 |
D/D |
(110) |
4,614 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
10,114 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2021-04-12 |
4 |
AS |
$32.12 |
$2,955 |
D/D |
(92) |
12,196 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2021-07-13 |
4 |
AS |
$35.02 |
$3,432 |
D/D |
(98) |
12,707 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2021-10-11 |
4 |
AS |
$30.23 |
$2,812 |
D/D |
(93) |
12,614 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-01-11 |
4 |
AS |
$25.95 |
$2,880 |
D/D |
(111) |
12,695 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
34,295 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-01-24 |
4 |
AS |
$24.88 |
$10,351 |
D/D |
(416) |
33,879 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-04-11 |
4 |
AS |
$35.74 |
$3,431 |
D/D |
(96) |
33,783 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-04-22 |
4 |
AS |
$32.92 |
$3,391 |
D/D |
(103) |
33,680 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-07-12 |
4 |
AS |
$24.03 |
$2,283 |
D/D |
(95) |
33,585 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-07-22 |
4 |
AS |
$24.67 |
$2,615 |
D/D |
(106) |
33,479 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-10-11 |
4 |
AS |
$23.79 |
$1,903 |
D/D |
(80) |
33,399 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2022-10-24 |
4 |
AS |
$19.58 |
$2,036 |
D/D |
(104) |
33,295 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
87,689 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
CFO and Treasurer |
|
2023-01-19 |
4 |
AS |
$43.80 |
$77,789 |
D/D |
(1,776) |
32,791 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|